Patents by Inventor Franco Lombardo

Franco Lombardo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060014788
    Abstract: CETP Inhibitors have improved solubility and bioavailability in a lipophilic vehicle comprising a digestible oil, a lipophilic solvent, or a surfactant. Preferred such compositions are self-emulsifying or self-microemulsifying, and comprise 1. a CETP inhibitor; 2. a cosolvent; 3. a surfactant having an HLB of 1 to 8; 4. a surfactant having an HLB of over 8 to 20; and 5. optionally, a digestible oil.
    Type: Application
    Filed: September 8, 2005
    Publication date: January 19, 2006
    Inventors: Michael Gumkowski, Franco Lombardo, Sharad Murdande, Michael Perlman
  • Patent number: 6548307
    Abstract: This invention provides a RP-HPLC method, for the determination of logPoct values, which combines ease of operation and high accuracy, and which has been shown to work for a set of 36 molecules largely comprised of drugs. The general features of the method are: i) compound sparing (≦1 mL of a 30-50 &mgr;g/mL solution needed), ii) rapid determinations (20 minutes on average), iii) low sensitivity to impurities, iv) wide lipophilicity range (6 logPoct units), v) good accuracy, vi) excellent reproducibility. A linear free energy relationship (LFER) analysis, based on solvation parameters, shows that the method encodes the same information obtained from a shake-flask logPoct determination. The value generated via this method is referred to as ElogPoct.
    Type: Grant
    Filed: February 13, 2001
    Date of Patent: April 15, 2003
    Assignee: Pfizer Inc.
    Inventors: Franco Lombardo, Marina Y. Shalaeva, Karl A. Tupper
  • Publication number: 20020161528
    Abstract: A RP-HPLC method for the determination of ElogDoct values for chemical compounds from retention time of each sample of the compound using (EQ1) drop in equation. This method has been shown to be effective on a set of 90 molecules.
    Type: Application
    Filed: February 21, 2002
    Publication date: October 31, 2002
    Applicant: Pfizer Inc.
    Inventors: Franco Lombardo, Marina Yevgenievna Shalaeva, Karl Andrew Tupper
  • Publication number: 20020009388
    Abstract: This invention provides a RP-HPLC method, for the determination of logPoct values, which combines ease of operation and high accuracy, and which has been shown to work for a set of 36 molecules largely comprised of drugs. The general features of the method are: i) compound sparing (≦1 mL of a 30-50 &mgr;g/mL solution needed), ii) rapid determinations (20 minutes on average), iii) low sensitivity to impurities, iv) wide lipophilicity range (6 logPoct units), v) good accuracy, vi) excellent reproducibility. A linear free energy relationship (LFER) analysis, based on solvation parameters, shows that the method encodes the same information obtained from a shake-flask logPoct determination. The value generated via this method is referred to as ElogPoct .
    Type: Application
    Filed: February 13, 2001
    Publication date: January 24, 2002
    Inventors: Franco Lombardo, Marina Y. Shalaeva, Karl A. Tupper